U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032
Overview
The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is expected to reach a 2.62 USD Billion by 2032 and is projected to grow at a CAGR of 5.58% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.71
Forecast, 2032 (USD Billion)
2.62
CAGR, 2024 - 2032
5.58%
Report Coverage
U.S.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market 2018-2032 USD Billion
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.71 USD Billion
- Projected Market Size (2032): 2.62 USD Billion
- CAGR (2025-2032): 5.58%
Key Findings of U.S. Graft-Versus-Host Disease (GVHD) Treatment Market
- The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market was valued at 1.71 USD Billion in 2024.
- The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is likely to grow at a CAGR of 5.58% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Medication in Treatment Segment accounted for the largest share of the market with a revenue of 1.60 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 6.02% during the forecast period from 2024 to 2032.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Scope
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Specialty Centers
- Institutes
- Transplant Centers
- Hospitals
Type
- Prophylactic
- Acute GVHD
- Chronic GVHD
Method of Administration
- Others
- Topical
- Intravenous
- Oral
Age
- Pediatric
- Adults
Gender
- Male
- Female
Treatment
- Therapy
- Medication
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.71 USD Billion |
| Market Value in 2032 | 2.62 USD Billion |
| CAGR (2025-2032) | 5.58% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Type,Method of Administration,Age,Gender,Treatment |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 1.71 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,712.12 USD Million in 2024.
Segments and Scope
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 824.38 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.90 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By End User
- Hospitals is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 761.61 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 6.02 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Type
- Chronic GVHD is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 798.47 USD Billion in the year 2024.
- Chronic GVHD is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.84 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Method of Administration
- Oral is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 796.99 USD Billion in the year 2024.
- Oral is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.87 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Age
- Adults is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 1.22 USD Billion in the year 2024.
- Adults is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.76 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Gender
- Female is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 969.98 USD Billion in the year 2024.
- Female is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.71 % in forecast period 2025-2032.
-
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032, By Treatment
- Medication is the largest segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a revenue of 1.60 USD Billion in the year 2024.
- Medication is the Fastest growing segment in U.S. Graft-Versus-Host Disease (GVHD) Treatment Market to 2032 with a Growth rate of 5.66 % in forecast period 2025-2032.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Company Share Analysis
| Company Name |
|
||
| Janssen Global Services, LLC | |||
| Incyte | |||
| Sanofi | |||
| Bristol-Myers Squibb Company | |||
| AbbVie Inc. | |||
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Method of Administration,Age,Gender,Treatment.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market was valued at USD 1.71(Revenue in USD Billion) in 2024.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is projected to grow at a CAGR of 5.58% during the forecast period of 2024 to 2032.
The Medication segment is expected to dominate the U.S. Graft-Versus-Host Disease (GVHD) Treatment Market, holding a largest market share of 1.60 USD Billion in 2024
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Scope
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Segmentation & Scope
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Specialty Centers
- Institutes
- Transplant Centers
- Hospitals
Type
- Prophylactic
- Acute GVHD
- Chronic GVHD
Method of Administration
- Others
- Topical
- Intravenous
- Oral
Age
- Pediatric
- Adults
Gender
- Male
- Female
Treatment
- Therapy
- Medication
Frequently Asked Questions
The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Method of Administration,Age,Gender,Treatment.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market was valued at USD 1.71(Revenue in USD Billion) in 2024.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is projected to grow at a CAGR of 5.58% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Graft-Versus-Host Disease (GVHD) Treatment Market for final year is USD 2.62 (USD Billion).
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market Company Profiling
Frequently Asked Questions
The U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is segmented based on Segmentation Distribution Channel,End User,Type,Method of Administration,Age,Gender,Treatment.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market was valued at USD 1.71(Revenue in USD Billion) in 2024.
U.S. Graft-Versus-Host Disease (GVHD) Treatment Market is projected to grow at a CAGR of 5.58% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Graft-Versus-Host Disease (GVHD) Treatment Market for final year is USD 2.62 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.